Roger Sidhu
Equibles does not estimate personal net worth.
Get an email with a short summary when Cardiff Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get CRDF alertsAbout Roger Sidhu
Cardiff Oncology, Inc. reported in an 8-K filed June 17, 2025 that Roger Sidhu was appointed Chief Medical Officer. Cardiff Oncology, Inc. reported in an 8-K filed June 17, 2025 that Roger Sidhu was appointed Chief Medical Officer, effective June 17, 2025. The proxy statement of Cardiff Oncology, Inc. reports total compensation of $2,273,805 for Roger Sidhu in fiscal 2025, including a base salary of $279,370. Cardiff Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cardiff Oncology, Inc. includes Mani Mohindru (CEO), Mani Mohindru, Ph.D. (CEO), Mark Erlander (CEO) and 7 others.
“Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced the company has appointed Roger Sidhu, MD, as Chief Medical Officer.”
“On June 17, 2025, the Company announced that it has appointed Dr. Roger Sidhu as its new Chief Medical Officer and entered into an employment agreement with Dr. Sidhu on June 16, 2025 (the "Sidhu Employment Agreement").”
Affiliation history
-
Cardiff Oncology, Inc. (CRDF)
Proxy statement
Current
Company network
Leadership on record at Cardiff Oncology, Inc.
- Mani Mohindru CEO
- Mani Mohindru, Ph.D. CEO
- Mark Erlander CEO
- Mark Erlander, Ph.D. CEO
- Thomas H. Adams CEO
- Rodney Markin, M.D. Chairman
- James Levine CFO
- Josh Muntner CFO
- Joshua Muntner CFO
- Ajay Aggarwal, MD, MBA COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cardiff Oncology, Inc. (CRDF) | CMO | $279,370 | $2,273,805 |